Moxydari CV 625 Tablets: A Powerful Combination for Bacterial Infections

Moxydari CV 625 tablets contain a synergistic combination of Amoxycillin (500mg) and Clavulanic Acid (125mg). This formulation offers broad-spectrum activity against various bacterial infections, including those resistant to single-drug therapies.

Amoxycillin is a first-generation beta-lactam antibiotic that targets bacteria's cell walls, effectively combating many common bacterial infections. Clavulanic acid, a beta-lactamase inhibitor, overcomes resistance mechanisms that may develop in bacteria. This combination provides enhanced efficacy against both susceptible and resistant strains.

Moxydari CV 625 tablets are indicated for treating respiratory tract infections like bronchitis, pneumonia, and sinusitis; urinary tract infections; skin and soft tissue infections; and other bacterial infections.

Consult your healthcare professional for proper diagnosis and treatment.